← FDA DRUG APPROVALS

FDA ANDA · ANDA072490

FLUOCINONIDE

Sponsor: TEVA

APPLICATION
ANDA072490
TYPE
ANDA
ORIGINAL APPROVAL
1989-02-07
LATEST ACTION
2001-08-30
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

FLUOCINONIDE EMULSIFIED BASEPrescription
FLUOCINONIDE 0.05% · CREAM · TOPICAL

Approval history

2001-08-30Manufacturing (CMC) · Supplement 18AP
2000-07-07Manufacturing (CMC) · Supplement 17AP
2000-02-17Manufacturing (CMC) · Supplement 16AP
1996-12-31Labeling · Supplement 15AP
1996-06-13Manufacturing (CMC) · Supplement 14AP
1995-08-07Manufacturing (CMC) · Supplement 13AP
1995-05-04Manufacturing (CMC) · Supplement 11AP
1995-05-04Manufacturing (CMC) · Supplement 9AP
1995-05-04Manufacturing (CMC) · Supplement 12AP
1995-05-04Manufacturing (CMC) · Supplement 10AP
1994-01-14Labeling · Supplement 5AP
1994-01-14Manufacturing (CMC) · Supplement 1AP
1993-08-31Manufacturing (CMC) · Supplement 7AP
1993-08-31Manufacturing (CMC) · Supplement 8AP
1993-08-31Manufacturing (CMC) · Supplement 6AP
1993-04-01Manufacturing (CMC) · Supplement 4AP
1993-04-01Manufacturing (CMC) · Supplement 3AP
1989-02-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →